This invention relates to pharmaceutical products and compositions for use inthe treatment of asthma and related disorders, and especially but notexclusively for the treatment of chronic obstructive pulmonary disease (COPD).More particularly, the invention provides pharmaceutical products andcompositions comprising specific anticholinergic agents, .beta.-2 agonists andcorticosteroids.